ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
52 hedge funds and large institutions have $3.26M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
11
Closed
7
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$3K
Top Buyers
1 |
RB
Richmond Brothers
Jackson,
Michigan
|
+$87.2K |
2 |
Millennium Management
New York
|
+$51.5K |
3 |
Renaissance Technologies
New York
|
+$11K |
4 |
Morgan Stanley
New York
|
+$10.9K |
5 |
BWP
Balboa Wealth Partners
Scottsdale,
Arizona
|
+$10.4K |
Top Sellers
1 |
BC
BIT Capital
Berlin,
Germany
|
-$566K |
2 |
BlackRock
New York
|
-$43.3K |
3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37K |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$19.2K |
5 |
CWA
CM Wealth Advisors
Beachwood,
Ohio
|
-$16K |